SequelSEC

Cardlytics, Inc. CDLX

Services-Computer Programming, Data Processing, Etc. · CIK 0001666071 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$36.88M
Fiscal year ended 2026-06-30
Operating income
-$5.44M
Fiscal year ended 2026-06-30
Free cash flow
-$8.60M
Fiscal year ended 2026-06-30

Cardlytics, Inc. (CDLX) reported revenue of $36.88M and net income of -$14.88M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Cardlytics, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Programming, Data Processing, Etc..

Income

Cardlytics, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$36.88M$34.32M$56.10M$52.03M$58.04M$56.44M$74.00M$67.06M$69.64M$67.61M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$5.44M-$8.27M-$6.10M-$68.85M-$9.57M-$11.12M-$8.31M-$148.55M-$15.81M-$22.83M
Net income-$14.88M-$4.48M-$8.25M-$72.67M-$9.28M-$13.28M-$15.59M-$145.18M-$4.26M-$24.28M
Research & development$5.54M$6.43M$7.96M$8.80M$9.87M$10.28M$9.90M$13.19M$13.47M$13.05M
Weighted-average diluted sharesshares 5.76Mshares 54.90MUnavailableshares 53.49Mshares 5.28Mshares 51.86MUnavailableshares 50.03Mshares 49.06Mshares 43.25M
Pretax income-$8.66M-$13.80M-$8.25M-$72.67M-$6.06M-$10.32M-$15.59M-$145.18M-$4.26M-$24.28M
Income tax expense$0$0UnavailableUnavailable$0$0UnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailable$-1.36$-0.18$-0.26Unavailable$-2.90$-0.09$-0.56
Selling, general & administrative$14.46M$15.04M$17.25M$18.72M$21.18M$23.32M$25.11M$25.24M$30.18M$28.60M
General & administrative$7.86M$8.28M$9.73M$10.85M$12.24M$12.94M$13.77M$12.08M$16.15M$14.48M
Selling & marketing$6.60M$6.76M$7.52M$7.86M$8.94M$10.38M$11.34M$13.16M$14.02M$14.12M

Balance

Cardlytics, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$28.04M$35.67M$48.72M$43.96M$46.74M$52.05M$65.59M$66.99M$71.25M$97.77M
Total assets$234.78M$263.91M$285.64M$292.81M$361.13M$369.07M$392.71M$399.39M$534.37M$568.95M
Current assets$101.07M$128.52M$137.28M$140.71M$150.40M$156.83M$177.98M$183.33M$185.33M$218.26M
Total liabilities$250.79M$267.91M$292.15M$297.51M$302.43M$304.98M$322.72M$329.70M$324.34M$369.81M
Current liabilities$62.35M$59.35M$78.39M$123.70M$129.15M$131.85M$148.96M$155.91M$104.60M$102.55M
Total equity incl. NCI-$16.00M-$4.00M-$6.51M-$4.70M$58.71M$64.09M$69.99M$69.70M$210.03M$199.14M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$67.64M$63.08M$82.46M$85.50M$93.19M$96.09M$103.25M$105.59M$102.67M$105.16M
Goodwill$110.30M$110.30M$110.30M$110.30M$159.43M$159.43M$159.43M$159.43M$277.20M$277.20M
Long-term debt$184.41M$204.20M$208.92M$214.64M$214.30M$213.94M$213.59M$213.24M$212.88M$257.87M
Accounts payable$1.24M$2.60M$2.66M$3.61M$1.94M$4.44M$3.69M$3.93M$4.87M$3.97M

Cash flow

Cardlytics, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$8.60M-$5.64M$13.01M$1.76M$1.22M-$6.71M$2.98M$1.38M$4.43M-$17.62M
Capital expenditures$2.00K$28.00K$25.00K$14.00K$322.00K$119.00K$123.00K$507.00K$281.00K$651.00K
Investing cash flow$20.92M-$2.30M-$2.28M-$4.46M-$4.66M-$3.90M-$4.09M-$5.26M-$4.66M-$4.75M
Financing cash flow-$20.08M-$5.02M-$6.02M-$12.00K-$2.06M-$3.03M-$202.00K-$388.00K-$26.29M$28.32M
Net change in cash-$7.63M-$13.05M$4.76M-$2.78M-$5.30M-$13.55M-$1.39M-$4.26M-$26.52M$5.94M
Stock-based compensation$2.36M$4.83M$5.51M$6.42M$7.50M$8.69M$8.67M$8.06M$12.64M$10.98M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailable$0UnavailableUnavailable-$309.00K$119.00KUnavailableUnavailable
Depreciation & amortization$4.06M$4.42M$6.20M$6.47M$4.24M$6.29M$5.94M$6.97M$6.53M$6.25M

Derived

Cardlytics, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow-$8.60M-$5.67M$12.98M$1.75M$903.00K-$6.82M$2.86M$878.00K$4.15M-$18.27M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin-14.8%-24.1%-10.9%-132.3%-16.5%-19.7%-11.2%-221.5%-22.7%-33.8%
FCF margin-23.3%-16.5%23.1%3.4%1.6%-12.1%3.9%1.3%6.0%-27.0%
SBC / revenue6.4%14.1%9.8%12.3%12.9%15.4%11.7%12.0%18.2%16.2%
Current ratio1.62x2.17x1.75x1.14x1.16x1.19x1.19x1.18x1.77x2.13x
Revenue YoY growth-36.5%-39.2%-24.2%-22.4%-16.7%-16.5%-10.4%Unavailable-9.2%5.1%
Net margin-40.3%-13.1%-14.7%-139.7%-16.0%-23.5%-21.1%-216.5%-6.1%-35.9%
R&D / revenue15.0%18.7%14.2%16.9%17.0%18.2%13.4%19.7%19.3%19.3%
CapEx / revenue0.0%0.1%0.0%0.0%0.6%0.2%0.2%0.8%0.4%1.0%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CDLX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-04View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationinconsistent2023-09-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-09-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.